In last trading session, Dogwood Therapeutics Inc (NASDAQ:DWTX) saw 0.36 million shares changing hands with its beta currently measuring 2.16. Company’s recent per share price level of $12.49 trading at -$0.27 or -2.12% at ring of the bell on the day assigns it a market valuation of $16.64M. That closing price of DWTX’s stock is at a discount of -134.43% from its 52-week high price of $29.28 and is indicating a premium of 87.03% from its 52-week low price of $1.62. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 15.53 million shares which gives us an average trading volume of 2.58 million if we extend that period to 3-months.

Dogwood Therapeutics Inc (NASDAQ:DWTX) trade information

Upright in the red during last session for losing -2.12%, in the last five days DWTX remained trading in the green while hitting it’s week-highest on Monday, 01/27/25 when the stock touched $12.49 price level, adding 42.65% to its value on the day. Dogwood Therapeutics Inc’s shares saw a change of 401.61% in year-to-date performance and have moved 9.56% in past 5-day. Dogwood Therapeutics Inc (NASDAQ:DWTX) showed a performance of 338.25% in past 30-days. Number of shares sold short was 4269.0 shares which calculate 0.17 days to cover the short interests.

Dogwood Therapeutics Inc (DWTX) estimates and forecasts

Statistics highlight that Dogwood Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 136.78% of value to its shares in past 6 months, showing an annual growth rate of 8.14% while that of industry is 16.00. Apart from that, the company came raising its revenue forecast for fiscal year 2025.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.02% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 13.86% while estimates for its earnings growth in next 5 years are of 5.11%.

On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 16.71 shares of worth $0.21 million or 1.25% of the total outstanding shares. The later fund manager was in possession of 5.94 shares on Oct 31, 2024 , making its stake of worth around $74215.0 in the company or a holder of 0.45% of company’s stock.